BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

In that moment, things clicked. A year ago, my father died after an absolutely brutal battle with amyotrophic lateral ...

By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...

A brain-computer interface has enabled people with paralysis to turn their thoughts directly into words, requiring less ...

In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...

When approached for a quote about Jeffrey D Rothstein, Professor of Neurology and Neuroscience and Director of the Brain Science Institute at Johns Hopkins School of Medicine (Baltimore MD, USA), his ...

Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...